Theravance, Inc. (THRX) Tops Q2 EPS by 2c

Theravance, Inc. (NASDAQ: THRX) reported Q2 EPS of ($0.42), $0.02 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $1.97 million.

For earnings history and earnings-related data on Theravance, Inc. (THRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Marchex (MCHX) Reports In-Line Q2 EPS
• Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c